Longevity Clinics.
— Residential programme · Montreux, Switzerland · Issue 04

Clinique La Prairie.

The original. Still the standard.

4.5 / 5 312 editorial verifications
From
CHF 38,000 / programme
Duration
7–21 days
Founded
1931
Languages
English · French · German · Italian · Russian · Arabic
77
— Editorial score · #11 of 19

Good, with caveats

How we score →
Diagnostic depth
22/25
Medical supervision
22/25
Conflict freedom
17/25
Evidence base
16/25
Conflict of interest: Structural

Diagnoses, prescribes and delivers in-house. The signature CLP cellular extract, IV nutrient infusions and other treatments are billed by the clinic that ordered the workup.

Experimental treatments: Labelled as experimental

Cellular therapy is presented as a long-standing house protocol rather than evidence-backed longevity medicine; the clinicians we spoke with are direct about its limits.

Medical director: Dr. Adrian Heini (Medical Director)
— The verdict

Worth it — for the patient who wants the genre defined for them.

The room you arrive in

A bay window, lake, alps. A nurse with a clipboard, then a doctor with a longer one. Clinique La Prairie has perfected the choreography of arrival — the part most clinics under-design — and you feel the ninety-four years of practice in the first quarter hour.

The Master Detox week, at roughly CHF 38,000, is the entry tier most readers should consider. Revitalisation, the seven-day flagship, sits closer to CHF 60,000 and includes the cellular therapy that made the place famous in 1931.

What you get for the price

A whole-body MRI on day one. Bloodwork at a depth — 300+ markers, twice — that most outpatient clinics charge €4,000 alone for. A cardiopulmonary exercise test. Epigenetic age via two clocks. Then a programme: nutrition, movement, infusions, hyperbaric, cryotherapy, sleep work. A doctor in attendance daily.

Calling it a medical hotel understates the medicine. Calling it a clinic misses the scale of the hospitality.

The cellular therapy question

CLP’s signature is its proprietary cellular extract, derived from sheep liver and administered as a course of injections. The clinical evidence for any anti-ageing effect remains, in 2026, unsettled. We won’t pretend otherwise.

What we will say: La Prairie doesn’t pretend either. The doctor who explained the protocol to us was direct about its mechanism (cytokine modulation, broadly), its limits (no individual longevity outcome data) and the patient profile it suits (post-fifty, in good health, looking for systemic recovery). That candour, in a category that traffics in promise, is itself worth something.

Where it falls short

For a reader in their forties looking for predictive medicine — risk stratification, biomarker pursuit, longitudinal protocol design — La Prairie is now the second-best answer to that question. Newer centres have built their entire practice around it. La Prairie’s strength remains the well-composed week, not the data-driven decade.

The verdict

Worth the cheque if you want the experience the genre is named after, served in its most refined form. Less worth it if you are buying a particular biomarker outcome — for which several clinics now compete, harder, on price.

Three Swiss clinics make a credible claim to this work. Only one was already doing it before insulin was discovered.